Noraxon Introduces MyoSystem 1400A at APTA Combined Sections Meeting
At the 2004 American Physical Therapy Association (APTA) Combined Sections Meeting in Nashville, Tennessee, Noraxon U.S.A. Inc. will present its latest surface electromyography (EMG) instrument, the MyoSystem 1400A. This fully functional fixed-cable instrument enables clinicians, biomechanical researchers, and sports medicine professionals to perform comprehensive muscle performance evaluations. The MyoSystem 1400A has 16 channels of surface EMG and/or other analog signals, a built-in USB port for simplified data acquisition, and is compatible with an extensive line of direct plug-in sensors and pre-amplifiers.
Key Takeaways:
- The MyoSystem 1400A is a highly versatile surface EMG device available in 4, 8, 12, or 16 channel units, with internationally patent-protected amplifier technology providing clean, consistent, and reliable SEMG signals.
- The instrument is compatible with a wide range of analog signals, including kinetic and kinematics variables, and is fully compatible with direct plug-in sensors and pre-amplifiers.
- MyoSystem 1400A is compliant with IEC60601-1 and IEC60601-2-40 electromyography standards and CE approved.
- Noraxon's EMG devices use patent amplifier technology for clean, consistent, and reliable data.
- Noraxon offers flexible products for use in various settings, including research, ergonomic, rehabilitation, and sports medicine applications.
Statistics:
- 16 channels of surface EMG and/or other analog signals
- 4, 8, 12, or 16 channel units available
- Built-in USB port for simplified data acquisition
- Internationally patent-protected amplifier technology
- IEC60601-1 and IEC60601-2-40 compatible
- CE approved
- Wide range of compatibility with direct plug-in sensors and pre-amplifiers
Sources:
- PRNewswire, "Noraxon to Introduce MyoSystem 1400A at APTA Combined Sections Meeting," February 3, 2004.
- Noraxon U.S.A. Inc., "About Noraxon U.S.A. Inc."
- Noraxon U.S.A. Inc., "MyoSystem 1400A."